Forbes: 3 Ways Technology Is Helping To Accelerate Industries In 2024
A recent Forbes article highlights Dotmatics as a leading tech company revolutionizing science in 2024 by showcasing how AI-driven innovations, advanced automation, and transformative technologies are accelerating growth, streamlining operations, and shaping the future across various industries.
In a recent Forbes feature, Dotmatics is recognized as a leading technology company revolutionizing science in 2024. The article explores three primary ways technology is accelerating growth and transformation across various industries. Key highlights include:
- The impact of AI-driven innovations on business processes and scientific research.
- Groundbreaking advancements in automation that are streamlining operations and increasing efficiency.
- The pivotal role of technology in shaping the future of business and driving unprecedented growth.
The article discusses the tools and trends that are propelling industries forward, emphasizing the importance of adopting new technologies to remain competitive in a rapidly evolving landscape.
Related
NBC News: How AI is Transforming Drug Discovery
In an NBC News segment, Alister Campbell, VP of Dotmatics, explains how the company leverages AI to analyze large datasets, predict effective drug compounds, and streamline fragmented data systems and manual workflows, thereby accelerating and improving the efficiency of drug discovery.
Dotmatics introduces Luma Agent: the AI co-scientist built on structured scientific data
Dotmatics has launched Luma Agent, an AI co-scientist integrated into its Luma Scientific Intelligence Platform, which leverages structured, ontology-backed scientific data to autonomously plan, execute, and manage complex scientific workflows—including data analysis, reporting, and platform configuration—delivering fully traceable, verifiable, and reproducible results with human-approved actions to accelerate lab work from days to minutes while ensuring governance and accountability.
U.S. News & World Report: How AI is Transforming Medicine and Patient Care
A U.S. News & World Report article highlights how AI-driven platforms like Dotmatics Luma are revolutionizing healthcare and life sciences by enabling scientists to efficiently manage large datasets, accelerate drug discovery, and enhance patient care through real-time data integration and decision-making.
From Foundational to Aspirational: Dotmatics CEO on the Three Phases of R&D Digital Transformation
Dotmatics CEO outlines the accelerating digital transformation in life sciences R&D driven by exploding data volumes, emphasizing the shift towards AI and machine learning despite unique industry challenges such as lack of standardized interoperability and a fragmented ecosystem, which complicate progress toward a predictive, generative AI-enabled future in drug discovery.
Addressing Inefficient R&D Workflows
The blog discusses how legacy, fragmented R&D systems hinder innovation in complex, multi-domain scientific research by creating silos and inefficiencies, and presents Dotmatics’ unifying platform as a comprehensive solution that integrates diverse tools, data, and teams to enable smarter collaboration, governed data use, and AI-driven automation for faster, more rigorous innovation.
NBC Louisiana: How AI is Accelerating Drug Discovery
In an NBC Louisiana feature, Dotmatics’ VP Phil Mounteney explained how AI is revolutionizing drug discovery by significantly reducing development time from up to ten years to potentially half, enhancing efficiency in analyzing vast data sets while ensuring data privacy by keeping sensitive information secure and in-house.